Clinical Trials Browser

Bile Duct Neoplasms × olaparib × Clear all

NCT04298021 2024-04-19

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Bile Duct Neoplasms

NCT04042831 2023-10-13

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Phase 2 Unknown

Gastrointestinal

Bile Duct Neoplasms